Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Gentoo Media - Mandatory notification of trade
-
Play to earn in Etaku - where Ecchi art meets Web3 gaming
-
HPH to Hold Extraordinary General Meeting and Class Meeting On October 31, 2024
-
Management Dealing in Securities
-
DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board
-
Volcon CEO John Kim Shares Important Company Update
-
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training
-
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
-
Mill City Ventures III, Ltd. Advances $2 Million To Award-Winning Holiday Light Maze Experience
-
Romance in Every Sunset: Phu Quoc's Salinda Luxury Boutique Resort Redefines Love Getaways
-
Verde Achieves Major Net Zero Milestone on NCAT Test Track
-
Royal Road Minerals' Subsidiary Qualifies for the Saudi Arabian Exploration Enablement Program
-
North Peak Announces Non-Brokered Private Placement
-
Caprock Announces Annual General & Special Meeting of Shareholders and Management Change
-
CanPR Reports Financial Results of Operating Subsidiary for Fiscal Year 2024
-
Tinley's Launches Hemp Delta 9 THC-Infused Beckett's Tonics At Total Wine & More
-
Atomic Minerals Corporation Updates Harts Point Uranium Project Drill Permitting Process in Partnership with Kraken Energy Corp.
-
Great Quest Drills 18m of 1.72 g/t Au including 8m at 3.72g/t Au at its BK2 Target, Namibia
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Reklaim Ltd. Announces Normal Course Issuer Bid to Protect Shareholder Value Amid Growing Demand for Consumer Data Privacy Solutions
-
U.S. GoldMining Intersects 652.5 meters at 1.00 g/t Gold Equivalent From Near-Surface Confirming Continuity of High-Grade Core at the Whistler Gold-Copper Deposit, Alaska
-
Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
-
KWILL Merchant Advisors ("KWILL") Leads Successful Funding Round for Low Profile's New Artist-First Publishing Division
-
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
-
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
-
Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2118 for Osteoporosis at ASBMR 2024
-
Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
Gaming and Leisure Properties Promotes Brandon Moore to Additional Role of President
-
ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
-
Salute Announces Investment from New Mountain Capital to Support Data Center Growth Trajectory
-
Marsh McLennan to Acquire McGriff Insurance Services
-
MariMed’s Betty’s Eddies Partners With Keep A Breast Foundation to Promote Breast Cancer Screening Education
-
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
-
DeFi Technologies Subsidiary Valour launches Asset-backed Ethereum Physical Staking ETP for Professional Investors on the London Stock Exchange
-
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
-
ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
-
BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
-
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Significant Metallurgical Advancement: Moving Toward a New Industry Standard for LiFePO4 Battery Feedstock
-
Adeia to Present at Upcoming Conferences on Hybrid Bonding Technology
-
Terex Corporation Announces Launch of Private Offering of $750 Million of Senior Notes Due 2032
-
Parsons to Announce Third Quarter 2024 Financial Results on October 30, 2024
-
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
-
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
-
Invesco Ltd: Form 8.3 - Learning Technologies Group PLC; Opening Position disclosure
-
Dr. Alejandro Duarte joins SEDA Expert’s Risk Management and Algorithmic Trading Expert Witness Practice
-
Electrovaya and Innovative Rail Technologies Enter into Strategic Supply Agreement for the Supply of Battery Systems for Electric Rail Applications
-
“Charming Beijing” Exhibition Highlights World Cultural Heritage for European Audiences
-
Global mayors exchange ideas in Hangzhou on sustainable urban development
